Skip to main content
OpenTrials

Clinical trial condition

Neuromuscular Junction Diseases

Explore clinical trials studying Neuromuscular Junction Diseases. Study availability and eligibility vary by location and protocol.

296 public trials 100 recruiting studies
Refine in advanced search Browse all conditions

Neuromuscular Junction Diseases trial results

Recruiting

MuSK Myasthenia 1000 Study

NCT06259071

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Immune System Diseases, +12 more
Locations
  • George Washington University Washington D.C., District of Columbia, United States
View Trial Details
Recruiting

Study of Aritinercept in Patients With Generalized Myasthenia Gravis

NCT07596901

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Immune System Diseases, +11 more
Locations
  • Aurinia Investigational Site Altamonte Springs, Florida, United States
  • Aurinia Investigational Site Boca Raton, Florida, United States
  • Aurinia Investigational Site Miami, Florida, United States
  • Aurinia Investigational Site Pasadena, California, United States
View Trial Details
Recruiting

A Study of Nipocalimab in Children Aged 2 to Less Than 18 Years With Generalized Myasthenia Gravis

NCT05265273

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Immune System Diseases, +10 more
Locations
  • Phoenix Children's Hospital Phoenix, Arizona, United States
  • Childrens Hospital Los Angeles Los Angeles, California, United States
  • Lucile Packard Children's Hospital Stanford Palo Alto, California, United States
  • UCSF Benioff Children's Hospital San Francisco, California, United States
View all 19 locations
View Trial Details
Recruiting

Study to Assess the Efficacy and Safety of IMVT-1402 in Participants With Mild to Severe Generalized Myasthenia Gravis

NCT07039916

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Generalized Myasthenia Gravis, +11 more
Locations
  • Site Number - 1056 Huntsville, Alabama, United States
  • Site Number - 1041 Mobile, Alabama, United States
  • Site Number - 1017 Phoenix, Arizona, United States
  • Site Number - 1025 Scottsdale, Arizona, United States
View all 88 locations
View Trial Details
Recruiting

A Study of Nipocalimab Administered to Adults With Generalized Myasthenia Gravis

NCT04951622

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Immune System Diseases, +10 more
Locations
  • Neuromuscular Research Center and Clinic Paradise Valley, Arizona, United States
  • HonorHealth Neurology Scottsdale, Arizona, United States
  • University of Southern California Los Angeles, California, United States
  • Stanford University Palo Alto, California, United States
View all 112 locations
View Trial Details
Recruiting

KYSA-6: A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy, in Patients With Generalized Myasthenia Gravis

NCT06193889

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Generalized Myasthenia Gravis, +11 more
Locations
  • Ronald Reagan UCLA Medical Center Los Angeles, California, United States
  • University of California, Irvine Orange, California, United States
  • Stanford University Medical Center Palo Alto, California, United States
  • University of Miami Miami, Florida, United States
View all 22 locations
View Trial Details
Recruiting

A Study of Telitacicept for the Treatment of Generalized Myasthenia Gravis (UPSTREAM MG)

NCT06456580

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Generalized Myasthenia Gravis, +11 more
Locations
  • HonorHealth Neurology - Bob Bové Neuroscience Institute Scottsdale, Arizona, United States
  • University of Southern California Los Angeles, California, United States
  • University of California Irvine Orange, California, United States
  • University of California San Francisco (UCSF) San Francisco, California, United States
View all 111 locations
View Trial Details

Related conditions